In vitro experiments on prostate cancer cell lines (e.g., LNCaP, PC-3) will verify the regulatory effects on AR signaling pathways, assessing PSA expression, cell processes, and using siRNA to distinguish interactions. This evidence concerns the gene KLK3 and Familial prostate cancer.